Turtle Cameron 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Turtle Cameron（CIK 1758363）在 1 家公司共报告 40 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 2,638 | $241,351 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 2,683 | $241,738 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 600 | $53,484 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 3,989 | $368,225 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 4,990 | $465,916 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 100 | $9,391 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 2,500 | $215,900 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 8,400 | $732,060 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 3,700 | $325,822 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 400 | $35,628 |
| 2026-08-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 5,635 | $540,566 |
| 2026-08-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 7,157 | $680,631 |
| 2026-08-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 800 | $75,176 |
| 2026-08-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 1,392 | $134,773 |
| 2026-08-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 16 | $1,559 |
| 2026-07-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 10,176 | $889,789 |
| 2026-07-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 4,234 | $373,100 |
| 2026-07-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 590 | $52,457 |
| 2026-06-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 3,557 | $246,856 |
| 2026-06-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 8,149 | $574,504 |
| 2026-06-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 3,294 | $235,126 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 5,300 | $368,562 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 3,600 | $254,772 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 1,000 | $71,760 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | 卖出 | 3,100 | $226,734 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02